Bactericidal activity of enoxacin and Lomefloxacin againstEscherichia coli KL16
- 1 August 1989
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 8 (8) , 731-733
- https://doi.org/10.1007/bf01963763
Abstract
Enoxacin and lomefloxacin were found to display a biphasic response when their bactericidal activities were investigated againstEscherichia coli KL16 in nutrient broth. Although enoxacin required bacterial protein and RNA synthesis to exert bactericidal activity, it was able to kill non-dividing bacteria. On the other hand, the protein synthesis inhibitor chloramphenicol and the RNA synthesis inhibitor rifampicin did not abolish enoxacin's killing activity againstEscherichia coli KL16 in nutrient broth. Lomefloxacin was also shown to be active against non-dividingEscherichia coli KL16.This publication has 15 references indexed in Scilit:
- 4-Quinolones and the SOS responseJournal of Medical Microbiology, 1989
- Laboratory assessment of lomefloxacin (SC-47111) in comparison with norfloxacinJournal of Antimicrobial Chemotherapy, 1988
- In-vitro assessment of lomefloxacin (SC-47111)—a new quinolone derivativeJournal of Antimicrobial Chemotherapy, 1988
- Pharmacokinetics and tissue penetration of orally administered lomefloxacinAntimicrobial Agents and Chemotherapy, 1988
- Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral dosesAntimicrobial Agents and Chemotherapy, 1988
- Pharmacokinetics of intravenous and oral enoxacin in healthy volunteersJournal of Antimicrobial Chemotherapy, 1988
- In vitro studies of S-25930 and S-25932, two new 4-quinolonesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Norfloxacin Has a Novel Bactericidal Mechanism Unrelated to That of Other 4-QuinolonesJournal of Pharmacy and Pharmacology, 1985
- The in vitro and in vivo activity of ciprofloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Enoxacin: worldwide in-vitro activity against 22451 clinical isolatesJournal of Antimicrobial Chemotherapy, 1984